Proteomics

Dataset Information

0

Senescence 2 - Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation


ABSTRACT: Bag3 and MVP regulate apoptosis resistance in Therapy Induced Senescence (TIS)

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell

DISEASE(S): Breast Cancer

SUBMITTER: judith coppinger  

LAB HEAD: Judith Coppinger

PROVIDER: PXD001013 | Pride | 2015-08-21

REPOSITORIES: Pride

altmetric image

Publications

Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation.

Pasillas Martina P MP   Shields Sarah S   Reilly Rebecca R   Strnadel Jan J   Behl Christian C   Park Robin R   Yates John R JR   Klemke Richard R   Gonias Steven L SL   Coppinger Judith A JA  

Molecular & cellular proteomics : MCP 20140705 1


Senescence is a prominent solid tumor response to therapy in which cells avoid apoptosis and instead enter into prolonged cell cycle arrest. We applied a quantitative proteomics screen to identify signals that lead to therapy-induced senescence and discovered that Bcl2-associated athanogene 3 (Bag3) is up-regulated after adriamycin treatment in MCF7 cells. Bag3 is a member of the BAG family of co-chaperones that interacts with Hsp70. Bag3 also regulates major cell-signaling pathways. Mass spectr  ...[more]

Similar Datasets

2015-08-21 | PXD001017 | Pride
2015-08-21 | PXD001016 | Pride
2015-08-21 | PXD001012 | Pride
2015-08-21 | PXD001014 | Pride
2015-08-21 | PXD001015 | Pride
2016-07-19 | MSV000079931 | MassIVE
2016-07-19 | MSV000079932 | MassIVE
2016-07-19 | MSV000079924 | MassIVE
2016-07-19 | MSV000079930 | MassIVE
2016-07-22 | MSV000079989 | MassIVE